Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly FCF Margin of 7717.17% in Q3 2025, up 37.78% quarter-over-quarter from 12403.11% in Q2 2025, and down 673688.0% on a YoY basis from N/an in Q3 2024.
Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' FCF Margin history runs 4 years deep, the most recent figure standing at 7717.17% for Q3 2025.
- In Q3 2025, FCF Margin fell 673688.0% year-over-year to 7717.17%; the TTM figure through Sep 2025 stood at 3519.33% (down 234456.0% YoY), while the FY2024 annual figure was 1255.57%, up 5267.0% from the prior year.
- FCF Margin was 7717.17% for Q3 2025 at Dianthus Therapeutics, up from 12403.11% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1399.91% in Q3 2022 to a low of 12403.11% in Q2 2025.
- Historically, FCF Margin has averaged 2606.08% across 4 years, with a median of 1713.16% in 2024.
- The sharpest annual moves came in 2024 and 2025: FCF Margin soared 71296 bps in 2024, then sank 1162238 bps in 2025.
- A 4-year view of FCF Margin shows it stood at 766.84% in 2022, then sank by 263 bps to 2784.98% in 2023, then rose by 26 bps to 2072.02% in 2024, then slumped by 272 bps to 7717.17% in 2025.
- The last three FCF Margin figures came in at 7717.17% (Q3 2025), 12403.11% (Q2 2025), and 2304.5% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7,717.17% |
| Jun 30, 2025 | -12,403.11% |
| Mar 31, 2025 | -2,304.50% |
| Dec 31, 2024 | -2,072.02% |
| Sep 30, 2024 | -980.29% |
| Jun 30, 2024 | -780.73% |
| Mar 31, 2024 | -1,713.16% |
| Dec 31, 2023 | -2,784.98% |
| Sep 30, 2023 | -1,117.44% |
| Jun 30, 2023 | -475.20% |
| Mar 31, 2023 | -2,163.45% |
| Dec 31, 2022 | -766.84% |
| Sep 30, 2022 | 1,399.91% |